Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial (Q45117188)
Jump to navigation
Jump to search
scientific article published on 23 March 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial |
scientific article published on 23 March 2012 |
Statements
1 reference
Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial (English)
1 reference
Hisao Ogawa
1 reference
Seigo Sugiyama
1 reference
Hirofumi Soejima
1 reference
Hideaki Jinnouchi
1 reference
Masafumi Nakayama
1 reference
Shiro Uemura
1 reference
Masao Kanauchi
1 reference
Naofumi Doi
1 reference
Yoshihiko Saito
1 reference
Masako Waki
1 reference
Sadanori Okada
1 reference
JPAD Trial Investigators
1 reference
Takeshi Morimoto
1 reference
Mio Sakuma
1 reference
23 March 2012
1 reference
1 reference
Identifiers
1 reference